These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 6139402
1. Selective killing of target cells by antibody-ricin A chain or antibody-gelonin hybrid molecules: comparison of cytotoxic potency and use in immunoselection procedures. Colombatti M, Nabholz M, Gros O, Bron C. J Immunol; 1983 Dec; 131(6):3091-5. PubMed ID: 6139402 [Abstract] [Full Text] [Related]
2. Sensitivity of target cells to immunotoxins: possible role of cell-surface antigens. Colombatti M, Bron C. Immunology; 1985 Jun; 55(2):331-8. PubMed ID: 2861156 [Abstract] [Full Text] [Related]
3. Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates. Sivam G, Pearson JW, Bohn W, Oldham RK, Sadoff JC, Morgan AC. Cancer Res; 1987 Jun 15; 47(12):3169-73. PubMed ID: 3495329 [Abstract] [Full Text] [Related]
4. Comparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies. Ramakrishnan S, Houston LL. Cancer Res; 1984 Jan 15; 44(1):201-8. PubMed ID: 6140077 [Abstract] [Full Text] [Related]
5. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain. Ramakrishnan S, Houston LL. Cancer Res; 1984 Apr 15; 44(4):1398-404. PubMed ID: 6142765 [Abstract] [Full Text] [Related]
6. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo. Thorpe PE, Brown AN, Bremner JA, Foxwell BM, Stirpe F. J Natl Cancer Inst; 1985 Jul 15; 75(1):151-9. PubMed ID: 3859688 [Abstract] [Full Text] [Related]
7. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma. Wiels J, Junqua S, Dujardin P, Le Pecq JB, Tursz T. Cancer Res; 1984 Jan 15; 44(1):129-33. PubMed ID: 6690030 [Abstract] [Full Text] [Related]
8. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen. Raso V, Ritz J, Basala M, Schlossman SF. Cancer Res; 1982 Feb 15; 42(2):457-64. PubMed ID: 6948605 [Abstract] [Full Text] [Related]
10. Cell-specific cytotoxicity expressed by a conjugate of ricin and murine monoclonal antibody directed against thy 1.1 antigen. Houston LL, Nowinski RC. Cancer Res; 1981 Oct 15; 41(10):3913-7. PubMed ID: 6116537 [Abstract] [Full Text] [Related]
11. Cytotoxicity acquired by conjugation of an anti-Thy1.1 monoclonal antibody and the ribosome-inactivating protein, gelonin. Thorpe PE, Brown AN, Ross WC, Cumber AJ, Detre SI, Edwards DC, Davies AJ, Stirpe F. Eur J Biochem; 1981 Jun 01; 116(3):447-54. PubMed ID: 6790277 [Abstract] [Full Text] [Related]
12. Thy 1.2+ leukemia cells eradicated from in vitro leukemia-bone marrow cell mixtures by antibody-toxin conjugates. Colombatti M, Colombatti A, Blythman HE, Bron C. J Natl Cancer Inst; 1984 May 01; 72(5):1095-9. PubMed ID: 6585586 [Abstract] [Full Text] [Related]
13. [In vitro and in vivo antitumor activity of monoclonal anti-MM46 antibody-ricin A chain conjugate]. Takahashi T, Seto M, Hara T. Gan To Kagaku Ryoho; 1983 Aug 01; 10(8):1894-1900. PubMed ID: 6882010 [Abstract] [Full Text] [Related]
14. T-cell killing of target cells induced by hybrid antibodies: comparison of two bispecific monoclonal antibodies. Clark MR, Waldmann H. J Natl Cancer Inst; 1987 Dec 01; 79(6):1393-401. PubMed ID: 3121901 [Abstract] [Full Text] [Related]
15. Specific cytotoxicity of a human immunoglobulin-directed Fab'-ricin A chain conjugate. Raso V, Griffin T. J Immunol; 1980 Dec 01; 125(6):2610-6. PubMed ID: 7430640 [Abstract] [Full Text] [Related]
16. Selective elimination of a B cell subset having acceptor site(s) for T cell-replacing factor (TRF) with biotinylated antibody to the acceptor site(s) and avidin-ricin A-chain conjugate. Hashimoto N, Takatsu K, Masuho Y, Kishida K, Hara T, Hamaoka T. J Immunol; 1984 Jan 01; 132(1):129-35. PubMed ID: 6418795 [Abstract] [Full Text] [Related]
17. Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber. Goldmacher VS, Blättler WA, Lambert JM, McIntyre G, Stewart J. Mol Pharmacol; 1989 Nov 01; 36(5):818-22. PubMed ID: 2531272 [Abstract] [Full Text] [Related]
18. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity. Pietersz GA, Kanellos J, McKenzie IF. Cancer Res; 1988 Aug 15; 48(16):4469-76. PubMed ID: 3260814 [Abstract] [Full Text] [Related]
19. Antibody-ricin conjugates: a method of linkage which blocks the galactose binding site of ricin. Foxwell BM, Ross WC, Thorpe PE. Behring Inst Mitt; 1984 May 15; (74):101-7. PubMed ID: 6477350 [Abstract] [Full Text] [Related]
20. Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates. Leonard JE, Wang QC, Kaplan NO, Royston I. Cancer Res; 1985 Nov 15; 45(11 Pt 1):5263-9. PubMed ID: 3876881 [Abstract] [Full Text] [Related] Page: [Next] [New Search]